Rhys Jones

2.0k total citations
34 papers, 744 citations indexed

About

Rhys Jones is a scholar working on Anesthesiology and Pain Medicine, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rhys Jones has authored 34 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Anesthesiology and Pain Medicine, 12 papers in Physiology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rhys Jones's work include Asthma and respiratory diseases (9 papers), Anesthesia and Pain Management (8 papers) and Anesthesia and Sedative Agents (8 papers). Rhys Jones is often cited by papers focused on Asthma and respiratory diseases (9 papers), Anesthesia and Pain Management (8 papers) and Anesthesia and Sedative Agents (8 papers). Rhys Jones collaborates with scholars based in United Kingdom, United States and Sweden. Rhys Jones's co-authors include A. C. Pearce, Dennis A. Smith, A. T. Lovell, R. Alexander, Simon J. Mantell, Mike Trevethick, C. Gildersleve, Anthony Harrison, Bahman Asgharian and Lea Ann Dailey and has published in prestigious journals such as Advanced Drug Delivery Reviews, Pain and Journal of Medicinal Chemistry.

In The Last Decade

Rhys Jones

33 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rhys Jones United Kingdom 16 225 214 162 149 128 34 744
Peter Seideman Sweden 21 75 0.3× 104 0.5× 41 0.3× 91 0.6× 119 0.9× 49 1.1k
V. Mandelli Italy 15 67 0.3× 156 0.7× 58 0.4× 165 1.1× 133 1.0× 52 764
William F. Hahne United States 23 68 0.3× 968 4.5× 398 2.5× 290 1.9× 229 1.8× 58 1.5k
W. Bolten Germany 17 46 0.2× 150 0.7× 32 0.2× 77 0.5× 73 0.6× 49 954
I Caruso Italy 15 74 0.3× 341 1.6× 25 0.2× 112 0.8× 45 0.4× 48 1.1k
Lisa Hickey United States 13 106 0.5× 217 1.0× 14 0.1× 210 1.4× 113 0.9× 31 684
Jong Wha Lee South Korea 14 111 0.5× 210 1.0× 120 0.7× 52 0.3× 122 1.0× 44 592
Julia Metzner United States 16 102 0.5× 254 1.2× 345 2.1× 112 0.8× 168 1.3× 35 943
M F Rack United States 13 87 0.4× 388 1.8× 22 0.1× 66 0.4× 51 0.4× 15 816
Baoguo Wang China 12 49 0.2× 323 1.5× 147 0.9× 46 0.3× 129 1.0× 46 681

Countries citing papers authored by Rhys Jones

Since Specialization
Citations

This map shows the geographic impact of Rhys Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rhys Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rhys Jones more than expected).

Fields of papers citing papers by Rhys Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rhys Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rhys Jones. The network helps show where Rhys Jones may publish in the future.

Co-authorship network of co-authors of Rhys Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Rhys Jones. A scholar is included among the top collaborators of Rhys Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rhys Jones. Rhys Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anders, Lars, Todd Van Arsdale, Sudhakar Chintharlapalli, et al.. (2024). 354P Synergistic preclinical efficacy through combination of the CDK4 and CDK2 selective inhibitors, PF-07220060 and PF-07104091, respectively, in HR+ HER2- breast cancer. Annals of Oncology. 35. S365–S365. 1 indexed citations
2.
Tess, David A., George Chang, Christopher Keefer, et al.. (2023). In Vitro-In Vivo Extrapolation and Scaling Factors for Clearance of Human and Preclinical Species with Liver Microsomes and Hepatocytes. The AAPS Journal. 25(3). 40–40. 26 indexed citations
3.
Cheruvu, N., Esther van Duijn, Ioana Barbu, et al.. (2023). The Metabolism of Lufotrelvir, a Prodrug Investigated for the Treatment of SARS-COV2 in Humans Following Intravenous Administration. Drug Metabolism and Disposition. 51(10). 1419–1427. 5 indexed citations
4.
Aspnes, Gary E., Elnaz Menhaji‐Klotz, Markus Boehm, et al.. (2021). Discovery and evaluation of non-basic small molecule modulators of the atypical chemokine receptor CXCR7. Bioorganic & Medicinal Chemistry Letters. 50. 128320–128320. 2 indexed citations
5.
Mowbray, Charles E., Andrew Bell, Michelle A. Collins, et al.. (2011). Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: A novel histamine H4 receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 21(21). 6596–6602. 29 indexed citations
6.
Millan, David S., Stephen A. Ballard, Paul A. Glossop, et al.. (2011). Design and synthesis of long acting inhaled corticosteroids for the treatment of asthma. Bioorganic & Medicinal Chemistry Letters. 21(19). 5826–5830. 11 indexed citations
7.
Selby, Matthew D., Andrew Bell, Andrew C. Mansfield, et al.. (2011). Discovery of a series of potent and selective human H4 antagonists using ligand efficiency and libraries to explore structure–activity relationship (SAR). Bioorganic & Medicinal Chemistry Letters. 21(21). 6591–6595. 4 indexed citations
8.
Jones, Rhys, et al.. (2011). Interpretation and prediction of inhaled drug particle accumulation in the lung and its associated toxicity. Xenobiotica. 42(1). 86–93. 44 indexed citations
9.
Forbes, Ben, Bahman Asgharian, Lea Ann Dailey, et al.. (2010). Challenges in inhaled product development and opportunities for open innovation. Advanced Drug Delivery Reviews. 63(1-2). 69–87. 94 indexed citations
10.
Mantell, Simon J., Rhys Jones, & Mike Trevethick. (2009). Design and application of locally delivered agonists of the adenosine A2Areceptor. Expert Review of Clinical Pharmacology. 3(1). 55–72. 21 indexed citations
11.
Brown, Alan D., Mark E. Bunnage, Paul A. Glossop, et al.. (2008). The discovery of adamantyl-derived, inhaled, long acting β2-adrenoreceptor agonists. Bioorganic & Medicinal Chemistry Letters. 18(4). 1280–1283. 28 indexed citations
12.
Smith, Dennis A. & Rhys Jones. (2008). The sulfonamide group as a structural alert: A distorted story?. PubMed. 11(1). 72–9. 34 indexed citations
13.
Mantell, Simon J., Peter T. Stephenson, Graham N. Maw, et al.. (2008). Inhaled adenosine A2A receptor agonists for the treatment of chronic obstructive pulmonary disease. Bioorganic & Medicinal Chemistry Letters. 18(4). 1284–1287. 18 indexed citations
14.
Hall, Judith, et al.. (2006). Author's reply. Pediatric Anesthesia. 16(5). 602–602.
15.
Hall, Janet E., et al.. (2005). Sevoflurane (12% and 8%) inhalational induction in children. Pediatric Anesthesia. 15(6). 470–475. 13 indexed citations
16.
Jones, Rhys, et al.. (2003). Detection of epidural catheters with ultrasound in children. Pediatric Anesthesia. 13(8). 681–684. 36 indexed citations
17.
Jones, Rhys, et al.. (2001). High‐dose intrathecal diamorphine for analgesia after Caesarean section. Anaesthesia. 56(1). 54–60. 12 indexed citations
18.
Jones, Rhys, et al.. (1999). Patient-Controlled Analgesia Using Remifentanil in the Parturient with Thrombocytopaenia. Obstetric Anesthesia Digest. 19(3). 160–170. 1 indexed citations
19.
20.
Jones, Rhys, et al.. (1989). Kinetics and potency of 1–653 in volunteers. Anesthesiology. 71(Supplement). A270–A270. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Seideman Breakdown of academic impact, for papers by V. Mandelli Breakdown of academic impact, for papers by William F. Hahne Breakdown of academic impact, for papers by W. Bolten Breakdown of academic impact, for papers by I Caruso Breakdown of academic impact, for papers by Lisa Hickey Breakdown of academic impact, for papers by Jong Wha Lee Breakdown of academic impact, for papers by Julia Metzner Breakdown of academic impact, for papers by M F Rack Breakdown of academic impact, for papers by Baoguo Wang
Rankless by CCL
2026